TP53 and hepatocellular carcinoma: In addition to miR-29, miR-621 has been shown to reduce the expression of SETDB1 by directly targeting its 3′ UTR and enhancing the radiosensitivity of HCC cells, which is mediated by the P53 signaling pathway [42].